Article Details

FDA Clears Cobas Liat Assay Panels for Point-of-Care Diagnosis of Sexually Transmitted Infections

Retrieved on: 2025-01-23 18:04:13

Tags for this article:

Click the tags to see associated articles and topics

FDA Clears Cobas Liat Assay Panels for Point-of-Care Diagnosis of Sexually Transmitted Infections. View article details on hiswai:

Excerpt

With FDA clearance and CLIA waiver, these STI assays join Roche's existing near-patient molecular testing portfolio for pathogens such as SARS-CoV-2, ...

Article found on: www.patientcareonline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo